Jan. 11, 2016
Eye Tech Care, a French company developing and marketing equipment for non-invasive glaucoma treatment in ophthalmology, announced on January 11, 2016 that it has secured a new round of funding from a Chinese investor. Everpine Capital will invest in two rounds for a total amount of around EUR 25 million and will support Eye Tech Care in its international expansion. The company will benefit from EVERPINE Capital’s presence in China in order to further continue product registration begun in 2015.
China represents a key market for Eye Tech Care, as 22 million people suffer from glaucoma in the country, representing 28% of people affected by the pathology worldwide. However, due to the relatively low quality level of care, only about 6% of the Chinese patients are treated.